{"date":"2025-05-09","count":43,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6919-2025-05-09-2200-h6zhjv","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"22:00:19","subject":"本公司受邀參加證交所舉辦之上市櫃公司與機構投資人法說會(COMPUTEX群雄競起 證交所精選25)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-05-09 22:00，「本公司受邀參加證交所舉辦之上市櫃公司與機構投資人法說會(COMPUTEX群雄競起 證交所精選25)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-05-09-2055-j8ws2v","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"20:55:30","subject":"本公司受邀參加摩根士丹利證券舉辦之英文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-05-09 20:55，「本公司受邀參加摩根士丹利證券舉辦之英文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-05-09-2054-dnqij3","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"20:54:33","subject":"本公司受邀參加凱基證券舉辦之中文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-05-09 20:54，「本公司受邀參加凱基證券舉辦之中文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-05-09-2039-g65std","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"20:39:09","subject":"本公司董事會通過和LENZ Therapeutics, Inc.(以下簡稱”LENZ”)簽署獨家授權合作協議。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-05-09 20:39，「本公司董事會通過和LENZ Therapeutics, Inc.(以下簡稱”LENZ”)簽署獨家授權合作協議。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-05-09-2035-vwp9dg","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"20:35:55","subject":"公告本公司董事會決議通過114年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-05-09 20:35，「公告本公司董事會決議通過114年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-05-09-1937-14f4mpb","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"19:37:24","subject":"董事會決議召開114年股東常會公告(新增召集事由)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-05-09 19:37，「董事會決議召開114年股東常會公告(新增召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-05-09-1928-kanx82","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"19:28:25","subject":"公告本公司董事會通過內部稽核主管及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-05-09 19:28，「公告本公司董事會通過內部稽核主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-05-09-1924-9qofud","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"19:24:29","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-05-09 19:24，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-05-09-1921-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"19:21:15","subject":"公告本公司董事會通過重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-05-09 19:21，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-05-09-1828-17893oj","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"18:28:12","subject":"公告本公司董事會通過114年度第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-05-09 18:28，「公告本公司董事會通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-05-09-1749-s5himv","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"17:49:29","subject":"公告本公司114年第1季合併財務報告業經提報董事會通過","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-05-09 17:49，「公告本公司114年第1季合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-05-09-1736-1emsqi3","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"17:36:40","subject":"公告本公司114年第1季合併財務報告業經提報董事會","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-05-09 17:36，「公告本公司114年第1季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-05-09-1729-1oq17s0","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"17:29:43","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-05-09 17:29，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-05-09-1719-i0lvvj","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"17:19:31","subject":"公告本公司董事會決議召開民國114年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-05-09 17:19，「公告本公司董事會決議召開民國114年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-05-09-1708-vu23x7","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-05-09","time":"17:08:53","subject":"公告本公司法人董事三顧股份有限公司改派代表人","clause":"第6款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-05-09 17:08，「公告本公司法人董事三顧股份有限公司改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-05-09-1643-qttxb0","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"16:43:17","subject":"公告本公司董事會通過114年度第一季財務報告","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-05-09 16:43，「公告本公司董事會通過114年度第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-05-09-1635-17bz8mt","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"16:35:31","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告","clause":"第22款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-05-09 16:35，「本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-05-09-1631-pngzzg","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"16:31:36","subject":"本公司董事會決議通過114年第1季合併財務報告案","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-05-09 16:31，「本公司董事會決議通過114年第1季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-05-09-1630-1waslb4","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"16:30:37","subject":"公告本公司董事會決議114年第1季股利發放","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-05-09 16:30，「公告本公司董事會決議114年第1季股利發放」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-05-09-1614-1vhfh08","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"16:14:42","subject":"公告本公司今日接獲註冊代理人通知，印度醫藥品監管機構(CDSCO)受理Bonvadis外用乳膏完全傷口適應症產品註冊申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-05-09 16:14，「公告本公司今日接獲註冊代理人通知，印度醫藥品監管機構(CDSCO)受理Bonvadis外用乳膏完全傷口適應症產品註冊申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-09-1612-vj07ty","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"16:12:34","subject":"更正本公司民國113年12月至114年3月之資金貸與資訊揭露明細表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-09 16:12，「更正本公司民國113年12月至114年3月之資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-09-1612-xrqs0z","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"16:12:16","subject":"更正本公司民國113年12月至114年3月之背書保證資訊揭露明細表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-09 16:12，「更正本公司民國113年12月至114年3月之背書保證資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2025-05-09-1609-100esni","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"16:09:13","subject":"公告本公司研發主管異動","clause":"第8款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2025-05-09 16:09，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-05-09-1607-vofjnx","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"16:07:08","subject":"公告本公司董事會通過民國114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-05-09 16:07，「公告本公司董事會通過民國114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-05-09-1551-zaw2nq","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"15:51:40","subject":"代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形","clause":"第51款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-05-09 15:51，「代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-05-09-1551-na0mu3","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"15:51:15","subject":"公告董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-05-09 15:51，「公告董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-05-09-1549-k6taya","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"15:49:40","subject":"本公司114年第一季合併財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-05-09 15:49，「本公司114年第一季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-05-09-1543-5rax5d","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"15:43:39","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-05-09 15:43，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-05-09-1542-1urxqie","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"15:42:35","subject":"公告本公司董事會通過114年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-05-09 15:42，「公告本公司董事會通過114年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-05-09-1542-b5tj95","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-05-09","time":"15:42:33","subject":"公告本公司發言人、財務主管、會計主管異動","clause":"第11款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-05-09 15:42，「公告本公司發言人、財務主管、會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-05-09-1541-1la36wq","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-05-09","time":"15:41:20","subject":"代重要子公司GOODEAL ENTERPRISES LIMITED公告辦理減資變更登記完成","clause":"第35款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-05-09 15:41，「代重要子公司GOODEAL ENTERPRISES LIMITED公告辦理減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-05-09-1526-1lgkrn6","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-05-09","time":"15:26:22","subject":"本公司申請新增劑型(軟膠囊劑)GMP查核乙案，已獲衛福部許可。","clause":"第44款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-05-09 15:26，「本公司申請新增劑型(軟膠囊劑)GMP查核乙案，已獲衛福部許可。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-05-09-1524-1rjiuzb","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"15:24:20","subject":"公告本公司114年第1季合併財務報告經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-05-09 15:24，「公告本公司114年第1季合併財務報告經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2025-05-09-1515-1oq17s0","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"15:15:54","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2025-05-09 15:15，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-05-09-1458-3yr1dt","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"14:58:01","subject":"公告本公司董事會決議不繼續辦理113年股東會通過之私募普通股案","clause":"第16款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-05-09 14:58，「公告本公司董事會決議不繼續辦理113年股東會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-05-09-1457-fegykh","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-05-09","time":"14:57:20","subject":"董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-05-09 14:57，「董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-05-09-1431-wsqazv","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"14:31:18","subject":"公告本公司董事會決議通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-09","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-05-09 14:31，「公告本公司董事會決議通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-05-09-1430-1oq17s0","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"14:30:43","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-05-09 14:30，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-05-09-1414-p405vg","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"14:14:46","subject":"公告本公司受邀參加中國信託證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-05-16","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-05-09 14:14，「公告本公司受邀參加中國信託證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-05-09-1407-29oxgg","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"14:07:11","subject":"公告本公司董事會決議召開114年股東常會 (增列其他議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-05-09 14:07，「公告本公司董事會決議召開114年股東常會 (增列其他議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-05-09-1400-15e2tvm","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"14:00:42","subject":"本公司董事會決議不分派114年第一季盈餘","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-05-09 14:00，「本公司董事會決議不分派114年第一季盈餘」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-05-09-1349-1we3v5x","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"13:49:47","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-05-09 13:49，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-05-09-1346-9qofud","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-05-09","time":"13:46:27","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-05-09 13:46，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}